Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up) [Phase 3]
Continuation study update for long-term safety of dupilumab in asthma patients from the TRAVERSE trial; completed phase 3 with posted result…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma [Phase 4]
Phase 4 trial comparing standard of care to eMDPI DS in participants aged 13 and older with asthma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: A Study to Test if TEV-48574 is Effective in Relieving Asthma [Phase 2]
Phase 2 trial of TEV-48574 in asthma was terminated; results posted in 2023.
-
FDA approval · 2023-03-08FDA Approved: LEVALBUTEROL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for levalbuterol products from Mylan Pharmaceuticals Inc. under the ANDA program. This action confir…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 clinical trial update on inhaler lung deposition in COPD and asthma, with results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Preschool Wheeze: Inflammation/Infection Guided Management [Phase 2]
Phase 2 clinical trial investigating guided management of preschool wheeze with focus on inflammation/infection for asthma; study completed …
-
FDA approval · 2023-03-01FDA Approved: FLUTICASONE FUROATE ELLIPTA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Furoate Ellipta from Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma [Phase 3]
Phase 3 trial update evaluating bioequivalence with a clinical endpoint for fluticasone propionate/salmeterol inhalation powder versus Advai…
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma [Phase 2]
Phase 2 trial investigating tezepelumab with methacholine-induced airway hyperresponsiveness in adults with mild allergic asthma; status and…
-
FDA approval · 2023-02-16FDA Approved: ALVESCO — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for ALVESCO (ciclesonide) submitted by Covis Pharma US, Inc. This action represents regulatory a…
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma [Phase 4]
Phase 4 trial update on the RECONSTRUCT study investigating disease mechanisms in asthma.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma [Phase 3]
Extension study assessing long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma; compl…
-
FDA approval · 2023-02-08FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic inhaled fixed-dose combination of fluticasone propionate and salmeterol by Hikma P…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults [Phase 2]
Phase 2 trial update assessing CREWS01 for reducing rescue inhaler use in adults with moderate to severe asthma.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Conducting Annual Asthma Reviews Using Telehealthcare: Comparison With Standard Care (Face-to-face Consultations) [NA]
A completed clinical trial comparing annual asthma reviews conducted via telehealthcare versus standard face-to-face consultations.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Managing Asthma Patients With AMAZE™: A Novel Disease Management Platform [NA]
Clinical trial update for AMAZE™, a novel disease management platform, studied in asthma patients. The study is completed with results poste…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Study of Dose-response to Bronchodilator and Dose-finding in Child 2.5 to 6 Years - Study Golden [Phase 2]
Phase 2 clinical trial updating dose-response and dose-finding of a bronchodilator in children aged 2.5 to 6 years with asthma (Study Golden…
-
FDA approval · 2023-02-01FDA Approved: TEZSPIRE — Supplemental Application (Amgen Inc)
The FDA approved a supplemental application for TEZSPIRE (tezepelumab-ekko) from Amgen, indicating an update related to its labeling or indi…
-
FDA approval · 2023-01-30FDA Approved: THEOPHYLLINE — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's original ANDA for theophylline, authorizing a generic version of theophylline. The approval supports its …
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma. [Phase 3]
Phase 3 trial update evaluating dupilumab on airway hyper-responsiveness and ventilation heterogeneity in asthma patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief [Phase 4]
Phase 4 trial update on a patient-empowered strategy to reduce asthma morbidity in highly impacted populations; results posted after complet…
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Anti-inflammatory Effects Glycopyrronium [Phase 3]
Phase 3 clinical trial update on glycopyrronium with anti-inflammatory effects in asthma and allergic asthma has completed.
-
FDA approval · 2023-01-10FDA Approved: AIRSUPRA — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved AirSupra, an original-application inhaled therapy combining albuterol sulfate and budesonide for asthma, developed by AstraZene…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of dupilumab in patients with persistent asthma has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma [Phase 2]
Phase 2 trial update for MSTT1041A in uncontrolled severe asthma completed; results posted.